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Abstract
Background: Egypt has by far the largest hepatitis C virus (HCV) prevalence in the world with 14.7% of the population being
antibody positive for HCV. The aim of this study was to examine the association between knowledge of HCV and HCV
antibody positivity among the Egyptian population.
Methods: We characterized different measures of HCV knowledge and examined their associations with HCV prevalence, by
analyzing a nationally representative database using standard epidemiologic methods. The database, the 2008 Egyptian
Demographic and Health Survey, included demographic, health, and HCV biomarker information for a sample of over
12,000 individuals.
Results: Basic knowledge of HCV was found to be high, but multiple gaps were identified in the specific knowledge of HCV
and its modes of transmission. There was no statistically significant difference in HCV prevalence between those who have
heard of HCV infection and those who have not (14.4% vs. 15.9%, p..05). Similar results were found for the other HCV
knowledge measures including those specific to HCV modes of transmission and to the sources of information for HCV
awareness. Logistic regression analyses did not demonstrate an association between HCV knowledge and HCV prevalence.
Conclusions: Our results do not provide support for an effect of awareness on reducing the risk of HCV infection in Egypt.
Public health messages directed at the lay public may not provide sufficient empowerment for individuals to avoid HCV
infection, and should be complemented with prevention programs to promote and strengthen infection control in the
settings of exposure, particularly in health care facilities.
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Background
Hepatitis C virus (HCV) is a global public health challenge [1].
HCV is a blood-borne RNA viral infection that is mainly
transmitted through direct exposure to infected blood such as
through sharing of injections, blood transfusions, and accidental
percutaneous exposures common in certain health-care profes-
sions [1,2]. Prevention of HCV transmission is predicated on well-
established infection control procedures for the prevention of
blood-borne pathogens in health care delivery systems throughout
the world [1,2]. These procedures include the screening of blood
supplies for HCV, in addition to other measures designed for
specific health-care settings such as hemo-dialysis centers where
reports of HCV outbreaks have been documented [3]. There are
also well-developed HCV prevention interventions among popu-
lation groups at high-risk of acquiring the infection such as
injecting drug users [4]. On the other hand, while HCV
transmission from mother to newborn is not frequent, interven-
tions to reduce such transmission have yet to be clearly identified
[5].
Egypt has by far the largest national-level HCV prevalence in
the world [6,7]. The estimated percentage of the Egyptian
population in the 15–59 years age group who are positive for
HCV antibody is 14.7% [8]. Over 80% of HCV infections in the
Egyptian population are among individuals aged 30 years and
above [8]. The re-use of needles during the parenteral antischis-
tosomal therapy campaigns in the 1960s and 1970s is a major
driver of the scale of this epidemic in Egypt [9]. Current HCV
incidence appears to be driven by exposures within the health care
system [8,10–14]. The scale of the HCV problem in Egypt
suggests the need for a specific epidemiologic strategy to prevent
HCV transmission at a national level.
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One public health measure in Egypt has been raising awareness
over the last decade about HCV by both governmental and non-
governmental stakeholders [15,16]. As of 2005, 80.6% of women
responding to the Egyptian Demographic and Health Survey
(EDHS) had heard about ‘‘hepatitis C illness’’ [17], probably one
of the highest levels globally. Nevertheless, widespread social
engagement, such as seen in other countries regarding the HIV/
AIDS epidemic, has not yet emerged in Egypt despite the severity
of the epidemic [18].
A search of the literature to date has not found any published
investigations on the evaluation of HCV awareness efforts in Egypt
as a prevention program. Although such an assessment can only be
implemented using a prospective study design, some insights about
the link between HCV awareness and risk of HCV infection can
be gained by analyzing cross-sectional data. To this end, we
characterized in this work HCV-related knowledge among the
Egyptian population and examined the association between HCV
awareness and HCV antibody prevalence. The overarching aim of
this study is to examine whether there is any signature that can
support whether a higher awareness of HCV infection in Egypt
could have contributed to a lower risk of HCV infection.
Materials & Methods
The EDHS 2008 national survey collected demographic and
health information from a nationally representative sample of the
resident Egyptian population with a large sample size and using a
rigorous sampling methodology [8]. Details related to the EDHS
sampling design, sample size, study instruments, data collection,
how informed consent was obtained, and other related method-
ology can be found in El-Zanaty et al. [8]. The EDHS data were
downloaded with permission from Measure DHS [19]. Unique to
this survey is the inclusion of HCV testing: out of 12,008
participants invited to give a blood specimen, 11,523 were tested
for HCV. Positive third-generation ELISA results were retested,
and all dual-positives were confirmed by chemiluminescent
microplate immunoassay. Quantitative real time RT-PCR was
used at the Egyptian Ministry of Health and Population Central
Laboratory for the detection of HCV RNA. A stringent quality
control system was also carried out in a separate government
laboratory. Further methodological details related to specimen
handling and laboratory methods employed for the detection of
HCV antibody and HCV RNA are also described in El-Zanaty
et al. [8]. The methodology used for the EDHS HCV serology
testing is robust, and it is unlikely that another cross-reacting
Flavivirus circulating in Egypt would have affected the sensitivity
or specificity of the HCV ELISA assay [6].
For the purpose of this study, we merged the EDHS individual
database with the HCV biomarker database based on established
guidelines for managing DHS data [20]. All individuals with a test
result for HCV antibody were included in our analysis. We
specifically characterized information related to exposure to HCV
knowledge that was collected in the EDHS. A list of the relevant
HCV knowledge questions along with the number label provided
for each question (Q) are presented in Table S1 of the Supporting
Information.
We subsequently examined the association between exposure to
HCV knowledge and HCV antibody positivity using prevalence
odds ratios (ORs) and their respective 95% confidence intervals
(CIs). These were derived from the implementation of chi square
tests and bivariate logistic regression analyses (Table 1). P-values
less than 0.05 were considered statistically significant.
An age-stratified analysis examining the association of HCV
knowledge variables with HCV antibody positivity among
individuals aged 30 years and younger and those aged more than
30 years was also conducted (Table 2). The possibility of having
age as an effect modifier for the association between knowledge of
HCV modes of transmission and HCV positivity was also
explored. To this end, we performed a likelihood ratio test that
compares the results of the logistic regression model that includes
age and each one of the knowledge of HCV modes of transmission
variables with an interaction term, to the parsimonious model
without the interaction term.
We further performed an age-stratified multivariate logistic
regression analysis to quantify the association between basic HCV
knowledge and HCV antibody positivity among adults aged 30
years and younger and those aged more than 30 years (Table 3).
The multivariate analysis was adjusted for sex (male/female),
educational attainment (no education/primary/secondary/higher
education), and place of residence (rural/urban).
We also constructed a composite score of the knowledge of
HCV modes of transmission variables including blood transfusion,
unclean needles, infected sharp objects, mother-to-child transmis-
sion, and lack of HCV transmission through casual physical
contact. In each of these variables, correct answers were coded ‘‘1’’
while non-correct answers were coded ‘‘0’’. We then conducted an
age-stratified multivariate logistic regression to examine the impact
of one-point increase in the knowledge score on HCV antibody
positivity controlling for sex, educational attainment, and place of
residence (Table 4).
We applied the sampling weights available in the EDHS
databases in all of our statistical calculations. The data were
analyzed using the statistical software of Epi Info 2000 and
STATA/SE version 11 (Stata Corp., 2009, College Station, TX,
USA).
Results
The EDHS was based on a nationally representative sample of
16,527 women aged 15 to 49 and a further subsample of 6,578
women and 5,430 men aged 15 to 59 (n= 12,008), of which,
11,523 completed the HCV biomarker testing. General informa-
tion related to the level of knowledge about HCV by socio-
demographic attributes can be found in the EDHS report [8].
Table 1 presents different measures of HCV knowledge and the
association between measures of HCV knowledge and HCV
antibody positivity. The table shows that 82.1% (95% CI: 81.3–
82.9%) of the sample responded that they had heard of HCV.
However, there was no statistically significant difference in HCV
prevalence between individuals who have heard of HCV and those
who have not heard of HCV (14.4% vs. 15.9%, p-value of 0.126).
Individuals who have not heard of HCV had 12% higher odds of
being HCV infected compared to their counterparts (95% CI:
0.97–1.31%). Similarly, there was no statistical difference in HCV
positivity by knowledge of HCV when stratified by place of
residence, with a higher exposure to HCV knowledge among
residents of urban areas versus residents of rural areas (86.4% vs.
79.1%). HCV positivity was higher among individuals reporting
receiving HCV information from multiple sources, however, the
association was either not significant or borderline significant with
limited epidemiological relevance (Table 1).
A substantial proportion of the Egyptian population had a
correct knowledge regarding the potential for HCV transmission
through blood transfusions (60.6%) and sharing of unclean needles
(50.9%). Still, the majority were not familiar with other routes of
HCV transmission such as sharp objects (34.9%) and mother-to-
child transmission (6.2%). Some also had misconceptions in
relation to specific modes of HCV transmission such as the belief
Awareness and Prevalence of Hepatitis C Virus
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Table 1. Prevalence of HCV antibody by response to HCV knowledge-related questions.
Variable Distribution HCV positive Odds ratio 95% Confidence interval p-value
(%) N=11,126 (%)
Question 601 ‘‘Have you ever heard of hepatitis C illness?’’
Yes 82.1 14.4 1.00
No 17.9 15.9 1.12 0.97–1.31 0.126
Question 601 ‘‘Have you ever heard of hepatitis C illness?’’
Among urban residents
Yes 86.4 10.3 1.00
No 13.6 10.6 1.04 0.74–1.47 0.822
Among rural residents
Yes 79.1 17.8 1.00
No 20.9 18.6 1.05 0.89–1.24 0.554
Question 603 ‘‘Where did you hear or see that information?’’
Television only 55.8 13.6 1.00 0.063
Television and other 33.9 16.0 1.20 1.01–1.43
Other than television 10.3 16.5 1.25 0.96–1.62
Question 604 ‘‘How is hepatitis C spread from one person to another?’’
Heterosexual sex
Yes 12.6 13.3 1.00
No/Don’t know 87.4 14.5 1.11 0.90–1.37 0.336
Homosexual sex
Yes 2.1 12.5 1.00
No/Don’t know 97.9 14.4 1.17 0.73–1.89 0.510
Blood transfusion
Yes 60.6 13.8 1.00
No/Don’t know 39.4 15.2 1.12 0.98–1.28 0.088
Unclean needles
Yes 50.9 13.6 1.00
No/Don’t know 49.1 15.2 1.09* 0.97–1.23 0.164
Sharp objects (e.g. razors)
Yes 34.9 14.5 1.00
No/Don’t know 65.1 14.3 0.99 0.86–1.13 0.875
Casual physical contact
Yes 14.2 15.3 1.00
No/Don’t know 85.8 14.2 0.92 0.77–1.10 0.365
Mother-to-child transmission
Yes 6.2 13.4 1.00
No/Don’t know 93.8 14.4 1.09 0.83–1.44 0.539
Other modes of transmission
Yes 0.4 19.0 1.00
No/Don’t know 99.6 14.4 0.71 0.32–1.61 0.419
Question 508 ‘‘The last time you had an injection, was the injection from a new, unopened package?’’
Among those who reported the safety procedure at the time they had their last injection (n = 1,417; 12.7%)
Yes 85.0 13.8 1.00
No 15.0 12.5 0.89 0.55–1.43 0.630
Question 509 ‘‘In the last 6 months have you heard, seen, or received any information about what people should do to be sure that injections are given safely?’’
Yes 22.8 12.6 1.00
No 77.2 15.2 1.24 1.07–1.43 0.004
*Un-weighted regression analysis due to failure to obtain a maximum likelihood using weighted data.
doi:10.1371/journal.pone.0069803.t001
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that HCV can spread through casual physical contact (14.2%). In
addition to the variability in the knowledge of HCV modes of
transmission, we found no significant differences in the levels of
HCV knowledge among HCV infected individuals and those not
infected with HCV (Table 1).
Only 12.7% of the total sample (n = 1,417) reported the safety
procedures that were followed the last time they received an
injection. Of these, 85% confirmed that the last injection they
received was from a new unopened package. No statistically
significant difference in HCV antibody positivity was observed
among those who did and those who did not report proper safety
procedures the last time they received an injection (13.8% vs.
12.5%, respectively, p-value of 0.630).
On the other hand, 22.8% of the total sample indicated that
they had received information in the last six months on injection
safety. Lower levels of HCV positivity were observed among this
group compared to the larger group who were not exposed to
injection safety information in the last six months (12.6% vs.
15.2%, respectively). The association was statistically significant
(OR: 1.24, 95%: CI 1.07–1.43) at the bivariate level, but did not
reach statistical significance (OR: 1.14, 95%: CI 0.98–1.32) in the
multivariate analysis after controlling for sex, educational attain-
ment, and place of residence (analysis not shown).
Table 2. Age-stratified analysis for the association between HCV knowledge-related questions and HCV antibody positivity among
the Egyptian population.
Variable Distribution (%) N=11,126 HCV positive (%) Odds ratio (95% Confidence interval)
Question 601 ‘‘Have you ever heard of hepatitis C illness?’’
Adults ,=30 years
Yes 81.1 5.0 1.00
No 19.0 6.4 1.29 (0.95–1.76)
Adults .30 years
Yes 83.3 23.8 1.00
No 16.7 27.0 1.18 (0.98–1.42)
Question 604 ‘‘How is hepatitis C spread from one person to another?’’
Adults ,=30 yearsAdults .30 years Adults ,=30 years Adults .30 years Adults ,= 30 years Adults .30 years
Heterosexual sex
Yes 11.8 13.3 4.1 21.5 1.00 1.00
No/Don’t know 88.1 86.7 5.2 24.1 1.27 (0.78–2.06) 1.16 (0.91–1.48)
Homosexual sex
Yes 1.6 2.6 9.1 14.7 1.00 1.00
No/Don’t know 98.4 97.4 5.0 24.0 0.52 (0.21–1.33) 1.83 (1.04–3.22)
Blood transfusion
Yes 60.2 61.1 4.8 22.8 1.00 1.00
No/Don’t know 39.8 38.9 5.5 25.3 1.17 (0.87–1.56) 1.15 (0.98–1.34)
Unclean needles
Yes 51.5 50.2 4.8 22.8 1.00 1.00
No/Don’t know 48.5 50.0 5.4 24.7 1.14 (0.86–1.52) 1.11 (0.96–1.30)
Sharp objects (e.g. razors)
Yes 34.4 35.3 4.6 24.2 1.00 1.00
No/Don’t know 65.6 64.7 5.3 23.5 1.17 (0.86–1.60) 0.96 (0.82–1.13)
Casual physical contact
Yes 14.1 14.3 5.8 24.7 1.00 1.00
No/Don’t know 85.9 85.8 4.9 23.6 0.84 (0.57–1.24) 0.94 (0.76–1.16)
Mother-to-child transmission
Yes 6.5 6.0 7.3 20.1 1.00 1.00
No/Don’t know 93.5 94.0 4.9 24.0 0.66 (0.39–1.09) 1.26 (0.89–1.77)
Other modes of transmission
Yes 0.3 0.5 0 31.9 NA* 1.00
No/Don’t know 99.7 99.5 5.06 23.7 NA* 0.66 (0.27–1.65)
Question 509 ‘‘In the last 6 months have you heard, seen, or received any information about what people should do to be sure that injections are given safely?’’
Yes 23.3 22.2 4.3 21.8 1.00 1.00
No 76.7 77.8 5.6 25.0 1.32 (0.96–1.83) 1.20 (1.01–1.42)
*NA: Not Applicable.
doi:10.1371/journal.pone.0069803.t002
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An age-stratified analysis revealed higher HCV antibody
positivity among adults older than 30 years of age compared to
younger adults (Table 2). Overall, minor or no differences were
observed in the association between the different aspects of HCV
knowledge and HCV positivity among the younger (#30 years)
versus the older adults (.30 years) (Table 2). Including age as an
effect modifier for the association between knowledge of HCV
modes of transmission variables and HCV antibody positivity did
not demonstrate better explanatory power to understand the
apparent lack of association between HCV knowledge and HCV
infection.
Table 3. Age-stratified multivariate logistic regression for the association between HCV antibody prevalence as dependent
variable and question 601 (Q601) ‘‘Have you ever heard of hepatitis C illness?’’ controlling for sex, educational attainment and
place of residence.
Independent variables Odds Ratio 95% Confidence interval p-value
Among adults aged 30 years and below
Q601 (no) 1.02 0.74–1.41 0.900
Sex (male) 1.56 1.20–2.03 0.001
Educational attainment (higher education) 1.00
Secondary education 1.45 0.95–2.21 0.088
Primary education 2.30 1.32–4.02 0.003
No education 3.14 1.87–5.27 0.000
Place of residence (rural) 1.80 1.29–2.52 0.001
Among adults above 30 years of age
Q601 (no) 0.99 0.81–1.21 0.950
Sex (male) 1.81 1.56–2.09 0.000
Educational attainment (higher education) 1.00
Secondary education 1.17 0.90–1.52 0.246
Primary education 1.59 1.20–2.11 0.001
No education 1.87 1.42–2.46 0.000
Place of residence (rural) 1.92 1.63–2.26 0.000
doi:10.1371/journal.pone.0069803.t003
Table 4. Age-stratified multivariate logistic regression for the association between HCV antibody prevalence as dependent
variable and knowledge of HCV modes of transmission score (with higher score indicating a higher knowledge level) controlling for
sex, educational attainment and place of residence.
Independent variables Odds Ratio 95% Confidence interval p-value
Among adults aged 30 years and below
Knowledge of HCV modes of transmission score* 1.00 0.88–1.14 0.974
Sex (male) 1.68 1.25–2.26 0.001
Educational attainment (higher education) 1.00
Secondary education 1.36 0.88–2.11 0.170
Primary education 2.12 1.14–3.94 0.018
No education 3.07 1.73–5.45 0.000
Place of residence (rural) 1.97 1.35–2.87 0.000
Among adults above 30 years of age
Knowledge of HCV modes of transmission score* 1.01 0.94–1.08 0.816
Sex (male) 1.94 1.65–2.29 0.000
Educational attainment (higher education) 1.00
Secondary education 1.22 0.93–1.60 0.143
Primary education 1.69 1.25–2.28 0.001
No education 1.89 1.41–2.53 0.000
Place of residence (rural) 1.87 1.57–2.24 0.000
*Knowledge of HCV modes transmission score includes knowledge of HCV modes transmission through blood transfusion, unclean needles, infected sharp objects,
mother-to-child transmission, and lack of transmission through casual physical contact. Correct answers were coded ‘‘1’’ while non-correct answers were coded ‘‘0’’.
doi:10.1371/journal.pone.0069803.t004
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Table 3 shows the results of an age-stratified multivariate logistic
regression where exposure to basic HCV knowledge (Q601) is
included in the model as a main independent variable along with
potential confounders such as sex, educational attainment, and
place of residence. The analysis revealed a lack of association
between exposure to this HCV knowledge measure and HCV
antibody positivity among both younger and older adults.
Conversely, moderate to strong associations were observed
between male-sex, lower educational attainment, and being a
resident of a rural area and HCV antibody positivity among both
age groups (Table 3).
Another age-stratified multivariate logistic regression examining
the association between a composite score of the knowledge of
HCV modes of transmission variables as a main independent
variable, and HCV positivity controlling for sex, educational
attainment, and place of residence also showed that a point
increase in the knowledge score was not associated with HCV
antibody positivity among both younger and older adults (Table 4).
The analysis also demonstrated that male-sex, lower educational
attainment, and being a resident of a rural area are main risk
factors for HCV infection among both age groups (Table 4).
Discussion
We characterized different aspects of HCV knowledge among
the population of Egypt; the country that has by far the highest
HCV prevalence in the world. We also explored associations
between different aspects of HCV knowledge and HCV infection.
Our analyses indicated that generally basic knowledge of HCV is
high in Egypt, not a surprising result considering the scale of the
HCV epidemic in this country and its associated disease morbidity
and mortality. Despite basic knowledge, comprehensive knowl-
edge of HCV and its modes of transmission cannot be described as
satisfactory in a country with such a level of disease burden. Our
analyses also generally revealed no significant differences in HCV-
related knowledge among HCV infected and HCV uninfected
individuals in both the younger and older adult generations in
Egypt. There was also no discernible signature for major
differences in the relationship between the various aspects of
HCV knowledge and HCV infection among the younger versus
the older adults.
Media outlets constitute the main sources of HCV knowledge
with television appearing to be the primary source. Exposure to
media might also explain the differences in exposure to HCV
knowledge among urban versus rural residents. These findings
pose questions related to the quality and type of information
(therapeutic vs. preventive) delivered to the average individual via
media channels. There is need to engage the media as key actors
in HCV prevention efforts, but through dissemination of accurate
prevention information that can empower individuals to avoid
HCV infection.
While the majority of the Egyptian population reported ever
hearing of HCV, a substantial proportion had poor levels of
knowledge in relation to several HCV modes of transmission.
Though a considerable proportion of the population is aware that
HCV can be transmitted through blood transfusions and sharing
of unclean needles, many were not able to recognize sharp objects
and mother-to-child transmission as potential modes of HCV
transmission. Others had also misconceptions regarding HCV
transmission. This highlights the need for both governmental and
non-governmental stakeholders working on raising HCV aware-
ness among the public to reinforce knowledge related to the modes
of transmission.
The lack of association between the different measures of HCV
knowledge and HCV infection do not, collectively, provide
support for an effect of awareness on reducing the risk of HCV
infection. Public health messages directed at the lay public do not
appear to provide sufficient empowerment for individuals to avoid
HCV infection. An alternative explanation for the lack of
association is that most HCV infected persons were infected
before they became aware of HCV, such as during the parenteral
antischistosomal therapy campaigns in the 1960s and 1970s [9].
Another explanation is that new HCV infections are acquired
within the context of the health care delivery systems [7,8,10–15],
and hence, may be beyond the individual’s ability to control
regardless of knowledge. Irrespective of the explanation, the lack of
association indicates that awareness programs cannot be sufficient
to prevent HCV transmission in Egypt, and must be comple-
mented with robust prevention programs to promote and
strengthen infection control in the settings of exposure, particularly
in health care facilities.
The effectiveness of infection control procedures for the
prevention of blood-borne pathogens in health care delivery
systems is well established [1–3]. Substantial reductions in HCV
incidence can be achieved by prioritizing prevention approaches
that target specifically the actual settings at which infected
individuals may pass the infection to uninfected individuals, that
is mainly the health care system [15]. This is particularly true in
Egypt in light of the documented need for improved injection
safety and infection control [21,22]. One success story to this end
is the infection control programs implemented by the Egyptian
Ministry of Health and Population in dialysis centers across Egypt
[15]. The programs yielded a substantial decrease in HCV
incidence from 28% to 6% among these patients [15].
Nevertheless, robust infection control programs that are
affordable and cost-effective in resource-rich settings may not be
affordable or cost-effective in a resource limited-setting such as
Egypt. For instance, a national HCV prevention intervention
program that costs only 10 US dollars per person per year would
require the allocation of close to one billion dollars in a country of
over 80 million inhabitants such as Egypt. This translates to almost
half the annual budget of the Ministry of Health and Population in
this country [7], which is already burdened by other needs and by
the high cost of providing treatment to HCV infected individuals.
The latter treatment program alone consumes about 20% of the
Ministry of Health and Population total annual budget [15].
Rigorous cost-effectiveness analyses are needed to examine the
impact and feasibility of different potential infection control
programs.
The principal objective of this investigation was to explore the
association between HCV knowledge and HCV antibody positiv-
ity among the Egyptian population, and to explore whether such
association is consistent with an assumed effect for awareness on
reducing the risk of HCV infection. Our findings did not provide
support for such an effect, but our approach is pragmatic and
empirical rather than etiologic. An etiologic investigation of public
awareness and HCV transmission would require HCV incidence
estimation in a representative sample ascertained to be free of
HCV and followed for an extended period of time. Such an
investigation is challenging by design and may not be justified
ethically, especially in the context of a randomized clinical trial,
given that the modes of HCV transmission are well established.
Our interpretation of the results of this analysis is limited by the
cross-sectional design of the EDHS survey. For any given
individual in the survey who was identified as HCV antibody
positive, the times of exposure to HCV awareness and of
acquisition of the HCV infection cannot be determined. Causal
Awareness and Prevalence of Hepatitis C Virus
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associations cannot be established. Our analysis is also limited by
the structure of the HCV knowledge-related questions in the
EDHS. Some of the questions are not sufficiently well-defined nor
are tied to a specific context or a time frame. Nevertheless, our
analyses are indicative of the need for more effective and targeted
HCV awareness efforts, and more so, emphasis on infection
control in the settings of exposure, particularly in health care
facilities.
To validate our findings, we conducted multiple analyses using
different HCV knowledge-related questions probing different
aspects of HCV knowledge. All analyses consistently showed a
lack of association between HCV knowledge and HCV prevalence
among both younger and older adults. We also conducted
sensitivity analyses to assess the robustness of our findings to
potential biases. It is conceivable that any individual respondent
could answer ‘‘yes’’ to Q601, ‘‘Have you ever heard of hepatitis C
illness?’’ out of social desirability. Such bias would reduce the
specificity of the question. To this end, we conducted a simulation
where the specificity and sensitivity to this question was modified
(not shown). Different simulations created changes in the
percentage of the population that answered ‘‘yes’’. Yet, the results
revealed persistently a lack of association between exposure to
HCV knowledge and HCV antibody positivity. This was expected
as misclassification bias, artificial or real, regarding an individual’s
response, had no effect on the specificity and sensitivity of the
HCV antibody ELISA assays which had been completed
independently, and at a later time after the interview.
Conclusions
Our results did not demonstrate an association between HCV
knowledge and HCV infection among the adult population of
Egypt. This finding does not provide support for an effect of
awareness on reducing the risk of HCV infection. Public health
messages directed at the lay public may not provide sufficient
empowerment for individuals to avoid HCV infection, and should
be complemented with robust prevention programs to promote
and strengthen infection control in the settings of exposure.
Substantial reductions in HCV incidence among the Egyptian
population can only be achieved through a combined approach
that reinforces both targeted and effective HCV awareness and
infection control in the health care delivery systems. Additional
studies are needed to evaluate the impact and cost-effectiveness of
potential prevention programs on reducing HCV transmission in
this country.
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